LIST OF NEW AND GENERIC DRUGS APPROVED BY FDA December 06, 2010 FDA +0 NEW AND GENERIC DRUG APPROVALS BY FDA FDA NEW AND GENERIC DRUG APPROVALS BY FDA
BRISTOL-MYERS SQUIBB AND PFIZER END STUDY ON ANTI-CLOTTING DRUG DUE TO BLEEDING December 06, 2010 acute coronary syndrome (ACS) Apixaban +2 APPRAISE-2 Trial BRISTOL-MYERS SQUIBB PFIZER STUDY ON ANTI-CLOTTING DRUG acute coronary syndrome (ACS) Apixaban APPRAISE-2 Trial BRISTOL-MYERS SQUIBB PFIZER STUDY ON ANTI-CLOTTING DRUG
SCIENTISTS FIND PROTEIN THAT MAY HELP TO CONTROL PROSTATE CANCER December 05, 2010 Bmi-1 protein Los Angeles PROSTATE CANCER PROTEIN UCLA study + University of California Bmi-1 protein Los Angeles PROSTATE CANCER PROTEIN UCLA study University of California
OBESITY PILL FAILS TO MEET ALL FDA CRITERIA December 05, 2010 Contrave FDA CRITERIA OBESITY PILL + Orexigen Therapeutics Inc Contrave FDA CRITERIA OBESITY PILL Orexigen Therapeutics Inc
QATAR BANS DEXTROPROPOXYPHENE December 05, 2010 +0 QATAR BANS DEXTROPROPOXYPHENE QATAR BANS DEXTROPROPOXYPHENE
AXIRON APPROVED AS FIRST UNDERARM TESTOSTERONE DRUG FOR MEN WITH SYMPTOMS OF HORMONE DEFICIENCY November 25, 2010 Acrux Axiron Eli Lilly FDA + topical testosterone Acrux Axiron Eli Lilly FDA topical testosterone
DCGI SUSPENDED ANTI-OBESITY DRUG DUE TO SIDE EFFECTS November 24, 2010 ANTI-OBESITY DRUG DCGI +0 Sibutramine ANTI-OBESITY DRUG DCGI Sibutramine
STATINS OK FOR PATIENTS WITH ABNORMAL LIVER FUNCTION: STUDY November 24, 2010 alanine aminotransferase (ALT) +1 atorvastatin liver non-alcoholoic fatty liver disease statins alanine aminotransferase (ALT) atorvastatin liver non-alcoholoic fatty liver disease statins
DAILY PILL PROTECTS AGAINST HIV INFECTION: STUDY November 23, 2010 antiretroviral pills HIV new york times.AIDS + Truvada antiretroviral pills HIV new york times.AIDS Truvada
NEW AND GENERIC DRUG APPROVALS BY FDA IN NOVEMBER November 18, 2010 FDA +0 NEW AND GENERIC DRUG APPROVALS BY FDA FDA NEW AND GENERIC DRUG APPROVALS BY FDA